HOME | 中文 | ENGLISH
Home
About Us
Wuxi Beita
Changsha Beita
Cooperation Units
Intellectual Property
Academic Publications
Qualification
Products
Radioisotope Labeled Products
Stable Isotope Labeled Products
Services
Technology Advantages
Labeling Service
Detection and Analysis Services
Customers
News
Beita News
Industry News
Media Coverage
Contact Us
Feedback
Information List
At the Forefront of Global Radiolabeled Drug Development: Wuxi Beita Pharmatech Invited to the International Isotope Society North American Chapter Annual Meeting, Its Research Widely Acclaimed
2026-11-12
Technology Update: Wuxi Beita Has Successfully Provided C-14 Labeling Services for 20 Antibody-Drug Conjugates
2026-10-14
CCTV·Excellent Teams of China丨Beita Pharmatech: Empowering People's Well-being with China's Nuclear Technology
2026-10-08
IIS–China Chapter Hosts 2nd Symposium on Innovation and Application of Isotope Science and Technology (2026) at SIMM, CAS
2026-05-20
Beta Pharmaceuticals "Carbon 14 Marking Technology Service" Approved "Wuxi High-tech Products (Services)"
2023-02-28
Beta Pharmaceuticals was approved to build "Wuxi Engineering Technology Research Center"
Beta Pharmaceuticals Selected in 2022 Jiangsu Province Science and Technology Enterprises "Listed Cultivation Library"
Promoting the application of carbon -14 isotopes in innovative pharmaceutical development and other fields, "Beta Pharmaceuticals" completed tens of millions of yuan in round B financing.
2022-10-28
Focus on isotope technology, beta pharmaceutical research and development to overcome C- 14 labeling key intermediate compounds.
Show new deeds, forge ahead on a new journey, and strive to be the vanguard of high-quality development -- Beta Pharmaceutical Party Branch organizes and studies the spirit of the Party's 20th National Congress report
2022-10-25
● Beita News
● Industry News
● Media Coverage